Invention Grant
US09487535B2 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
有权
用作治疗剂的螺 - 羟吲哚化合物的不对称合成
- Patent Title: Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
- Patent Title (中): 用作治疗剂的螺 - 羟吲哚化合物的不对称合成
-
Application No.: US13794147Application Date: 2013-03-11
-
Publication No.: US09487535B2Publication Date: 2016-11-08
- Inventor: Shaoyi Sun , Jianmin Fu , Sultan Chowdhury , Ivan William Hemeon , Michael Edward Grimwood , Tarek Suhayl Mansour
- Applicant: Xenon Pharmaceuticals Inc.
- Applicant Address: CA Burnaby
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby
- Agency: Seed IP Law Group PLLC
- Main IPC: C07D491/20
- IPC: C07D491/20 ; C07D209/34 ; C07D405/10 ; C07D491/107
Abstract:
This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Public/Granted literature
- US20130274483A1 ASYMMETRIC SYNTHESES FOR SPIRO-OXINDOLE COMPOUNDS USEFUL AS THERAPEUTIC AGENTS Public/Granted day:2013-10-17
Information query
